Massive Real-World Study with the VA Indicates Dramatic Decline in COVID-19 Vaccine Effectiveness—Janssen to 13% in 6 Months!

A recent study involving 780,225 Veterans and published in Science investigated COVID-19 breakthrough infections in this population. Led by the Public Health Institute, the Veterans Affairs Medical Center, and the University of Texas Health Science Center, problematic findings were discovered that raised questions about the underlying mass vaccination campaign ongoing as a primary means of eradicating COVID-19. Specifically, the investigational team in this real-world study found a marked decline in vaccine effectiveness for the Johnson and Johnson (Janssen) vaccine from 86.4% in March to 13.1% in September. But, dramatic declines in the Pfizer-BioNTech and Moderna mRNA-based vaccines support other studies TrialSite has covered that reflect this undeniable trend. While the findings that showed “vaccination of any type” helped to reduce the death rate among infected individuals, the dramatically lower rates of effectiveness evidenced real emerging problems. The vaccine doesn’t help substantially stop transmission past a handful of months. While a booster may resuscitate immune response, how do these findings fit into the current government narrative?

Recently written up by the P...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee